Hydrocortisone 1% In Absorbase Side Effects

Generic name: hydrocortisone topical

Medically reviewed by Drugs.com. Last updated on Jul 6, 2024.

Note: This document provides detailed information about Hydrocortisone 1% In Absorbase.

For Healthcare Professionals

Applies to hydrocortisone topical: compounding powder, rectal cream with applicator, rectal foam, rectal ointment, rectal solution, rectal suppository, topical cream, topical foam, topical gel, topical kit, topical lotion, topical ointment, topical pad, topical paste, topical solution, topical spray, topical stick Side Effects associated with hydrocortisone topical. Some dosage forms listed on this page may not apply specifically to the brand name Hydrocortisone 1% In Absorbase.

For Healthcare Professionals

Applies to hydrocortisone topical: compounding powder, rectal cream with applicator, rectal foam, rectal ointment, rectal solution, rectal suppository, topical cream, topical foam, topical gel, topical kit, topical lotion, topical ointment, topical pad, topical paste, topical solution, topical spray, topical stick.

General

The most commonly reported side effects were burning, itching, irritation, dryness, and folliculitis.^[Ref]

Cardiovascular

• Frequency not reported: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis^[Ref]

Endocrine

• Frequency not reported: HPA axis suppression, decreased carbohydrate and glucose tolerance, development of cushingoid state, glycosuria, hirsutism, hypertrichosis, increased requirements for insulin or oral hypoglycemic agents in diabetes, manifestations of latent diabetes mellitus, menstrual irregularities, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery, or illness), suppression of growth in pediatric patients^[Ref]

Immunologic

• Frequency not reported: Decreased resistance to infection, concomitant skin infections^[Ref]

Ocular

• Frequency not reported: Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, rare instances of blindness associated with periocular injections^[Ref]

Psychiatric

• Frequency not reported: Depression, emotional instability, euphoria, insomnia, mood swings, personality changes, psychic disorders^[Ref]

Local

• Frequency not reported: Burning, itching, irritation, dryness, folliculitis^[Ref]

Gastrointestinal

• Frequency not reported: Abdominal distention, nausea, pancreatitis, peptic ulcer with possible perforation and hemorrhage, perforation of the small and large intestine (particularly in patients with inflammatory bowel disease), ulcerative esophagitis^[Ref]

Musculoskeletal

• Frequency not reported: Aseptic necrosis of femoral and humeral heads, Charcot-like arthropathy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, steroid myopathy, tendon rupture, vertebral compression fractures^[Ref]

Hypersensitivity

• Frequency not reported: Anaphylactoid reaction, anaphylaxis, angioedema^[Ref]

Respiratory

• Frequency not reported: Pulmonary edema

Dermatologic

• Frequency not reported: Acne, allergic dermatitis, cutaneous and subcutaneous atrophy, dry scaly skin, ecchymoses and petechiae, edema, erythema, hyperpigmentation, hypopigmentation, impaired wound healing, increased sweating, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria, miliaria, telangiectasia^[Ref]

Metabolic

• Frequency not reported: Fluid retention, hypokalemic alkalosis, potassium loss, sodium retention, negative nitrogen balance due to protein catabolism, increased appetite, weight gain^[Ref]

Hepatic

• Frequency not reported: Elevation in serum liver enzyme levels (usually reversible upon discontinuation), hepatomegaly^[Ref]

Nervous system

• Frequency not reported: Convulsions, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, neuritis, neuropathy, vertigo^[Ref]

Other

• Frequency not reported: Abnormal fat deposits, hiccups, increased or decreased motility and number of spermatozoa, malaise^[Ref]

Further information

Hydrocortisone 1% In Absorbase side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer